WOMAC ® Osteoarthritis Index logo

WOMAC® 3.1 User Guide XII

The following is the Table of Contents from the WOMAC® 3.1 User Guide XII.

FOREWORD

OVERVIEW

CONCEPTUAL BASIS

DERIVATION OF THE ITEM INVENTORY

VALIDATION STUDIES (RELIABILITY, VALIDITY, RESPONSIVENESS)

Orthopaedic Validation Study
Pharmacologic Validation Study

SPECIFIC CLINIMETRIC ISSUES

Likert vs Visual Analogue Scaling
Prior Score Availability
Time Frame Dependency
Signal vs Aggregate Measurement
Parametric vs Non-Parametric Analysis
Relative Efficiency
Weighting and Aggregation
Alternate Language Translations
Rasch Analyses
Predictive Value
SF-WOMAC
Applications in Studies of Purported Structure-Modifying Drugs in OA
Applications in non-OA disorders

ADMINISTRATIVE ISSUES

Formatting the Index
Index Presentation
Score Calculation
Scale Transformation Issues
Statistical Issues

SCORE INTERPRETATION ISSUES

Responder Criteria
State-attainment Criteria
Population-based Age- and Gender-Specific Normative Values

ELECTRONIC DATA CAPTURE (EDC)

GUIDANCE DOCUMENTS

OMERACT Core Set Measures for OA
OARSI Clinicial Trials Guidelines
IMMPACT Guidelines for Pain Studies
FDA Guidance Document on Patient Reported Outcome Measures
EMA Guidance Document on Clinical Investigation of Medicinal Products in OA

REFERENCES

APPENDICES

Appendix I: WOMAC® Language List
Appendix II: An Explanation Of The Meaning of Questions In The WOMAC® Osteoarthritis Index Inventory

RELATED OSTEOARTHRITIS PRO MEASURES

Australian/Canadian (AUSCAN) Osteoarthritis Hand Index
Osteoarthritis Global Index (OGI)
Osteoarthritis Modular Measurement System (O2MS)

Return to WOMAC® 3.1 Index